Opioid-Free Anesthesia Versus Opioid Based Anesthesia For Adolescent Idiopathic Scoliosis

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age8-18
SponsorNashwa Ahmed

About this trial

Opioid-free anesthesia (OFA) is a multimodal analgesic approach designed to eliminate the intraoperative use of systemic, neuraxial, or intracavitary opioids. This technique employs a combination of antinociceptive agents targeting various pathways within the central and peripheral nervous systems to achieve effective analgesia.

Dexmedetomidine (DEX), a highly selective α2-adrenoreceptor agonist, is a centrally acting non-opioid agent increasingly utilized in clinical practice for its antinociceptive and anxiolytic properties. Only a few prospective randomized controlled trials have specifically examined the postoperative analgesic efficacy of intraoperative dexmedetomidine infusion in patients undergoing spinal surgery, with limited data focusing on this as a primary endpoint. Importantly, no clinical studies have investigated its analgesic impact in patients undergoing spinal surgery under general anesthesia.

Eligibility criteria

Qualifiers

None

Disqualifiers

Non-idiopathic scoliosis

Contraindications to commonly used perioperative medications

ASA Physical Status ≥ III

Presence of neuromuscular disorders or severe cardiac dysfunction

Trial design

Treatments tested in this trial

  • Dexmedetomidine
  • Fentanyl (IV)

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Nashwa Ahmed

Lead sponsor

Port Said University hospital

Sponsor institution